• the second-line drug supply chain for treatment of MDR TB (Chapter 8); and
  • the development of new TB diagnostics and drugs (Chapter 9).

Each of these chapters opens with a box listing the key messages emerging from the workshop presentations and discussions, as identified by the workshop rapporteurs. Finally, Chapter 10 looks back at the major viewpoints expressed at the workshop and looks forward to next steps suggested by workshop participants.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement